Search Results for "President CEO Epicentre Biotechnologies"

01:44 EDT 5th September 2015 | BioPortfolio

Matching Channels

Drug Development for Rare Diseases

The economics of any industry relies on a large demand for a particular product; this applies to the pharmaceutical industry where efforts are focused on big and relatively straight-forward diseases...

Matching News

Better hygiene in schools in Ebola epicentre pays off: UN

Better hygiene in schools in Liberia, Sierra Leone and Guinea—the epicentre of the Ebola epidemic—has dramatically cut infections among teachers and students, the UN said on Wednesday.

AXIM Biotechnologies Clarifies Relationship With Medical Marijuana, Inc. and CanChew Biotechnologies, LLC

NEW YORK, July 31, 2015 (GLOBE NEWSWIRE) -- A statement from AXIM Biotechnologies (OTC:AXIM), an innovative biotechnology company: "We have received numerous telephone calls from the public leading...

ExpreS2ion Biotechnologies – production in Drosophila S2 cells

ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 recombinant protein tec...

Avalanche Biotechnologies tanks on decision not to proceed to Phase IIb with AVA-101

Avalanche Biotechnologies (Nasdaq: AAVL) on Friday unexpectedly reported that, following further analyses…

Immatics US launches with $40mm Series A investment from parent Immatics Biotechnologies

Cancer immunotherapies developer Immatics Biotechnologies GMBH and the University of Texas MD Anderson Cancer Center together launched Immatics US Inc., a new adoptive cellular therapeutics (ACT) subs...

Benitec inks deal with China's Biomics Biotechnologies

Biospectrum Benitec acquires full rights to pre-clinical hepatitis B program from Biomics Biotechnologies [Read more]

Adaptive Biotechnologies to open East Coast office

Seattle-based Adaptive Biotechnologies plans to establish an office in New York City to house its business development and co -More- 

AVALANCHE BIOTECHNOLOGIES, INC. SHAREHOLDER UPDATE: Kessler Topaz Meltzer & Check, LLP Announces Update to Class Action and Reminds Avalanche Biotechnologies, Inc. Shareholders of Impending Deadline -- AAVL

RADNOR, Pa., Sept. 01, 2015 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Avalanche Biotechno...

Matching PubMed Articles

Nancy L. Ascher, MD, PhD: Professor and Chair, Department of Surgery, UCSF; Past-President, ASTS; President-elect, The Transplantation Society.

A New Initiative on Precision Medicine.

"Tonight, I'm launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes - and to give all of us access to the personalized information we need to kee...

The Assassination of Abraham Lincoln and the Evolution of Neuro-Trauma Care: Would the 16(th) President Have Survived in the Modern Era?

Abraham Lincoln was the 16(th) President of the United States of America. On April 14, 1865, shortly after his re-election and the conclusion of the Civil War, Lincoln was shot and killed by John Wilk...

Epidemiology, Ecology and Gene Pool of Influenza A Virus in Egypt: Will Egypt be the Epicentre of the Next Influenza Pandemic?

Abstract Outside Asia, Egypt is considered to be an influenza H5N1 epicentre and presents a far greater pandemic risk than other countries. The long-term endemicity of H5N1 and the recent emergence of...

Message From the President.

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement